Cryo-Cell International (CCEL) vs Mangoceuticals (MGRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Cryo-Cell International is the larger company by market cap ($33.5 million vs $2.7 million), about 12.2 times the size. Cryo-Cell International converts more of its revenue into profit, with a net margin of -7.7% versus -4526.8%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CCEL | MGRX |
|---|---|---|
| Share price | $4.15 | $0.1236 |
| Market cap | $33.46M | $2.75M |
| 1-day change | 0.00% | -7.55% |
| YTD return | +20.64% | — |
| 1-year return | +1.47% | — |
| 5-year return | -66.34% | — |
| Forward P/E | 207.50 | — |
| EPS (TTM) | $-0.24 | $-0.52 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $31.57M | $456.02K |
| Revenue growth (YoY) | -1.31% | -25.96% |
| Net income (latest FY) | $-2.43M | $-20.64M |
| Gross margin | 76.63% | 54.91% |
| Operating margin | 1.53% | -3954.28% |
| Net margin | -7.70% | -4526.76% |
| 52-week high | $5.45 | $1.38 |
| 52-week low | $2.72 | $0.121 |
| Distance from 52-week high | -23.85% | -91.04% |
| Average volume | 13.02K | 638.90K |
| Shares outstanding | 8.06M | 22.22M |
| Employees | 72 | 3 |
| Sector | Health Care | Health Care |
| Industry | Misc Health and Biotechnology Services | Misc Health and Biotechnology Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Cryo-Cell International is about 12.2 times larger than Mangoceuticals by market value ($33.46M vs $2.75M).
- Cryo-Cell International is more profitable, keeping -7.7 cents of every revenue dollar as net income versus -4526.8 cents for Mangoceuticals.
- Cryo-Cell International grew revenue faster in its latest fiscal year (-1.31% vs -25.96%).
About Cryo-Cell International
CCEL stock →Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States.
Health Care · Misc Health and Biotechnology Services · 72 employees
About Mangoceuticals
MGRX stock →Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States.
Health Care · Misc Health and Biotechnology Services · 3 employees
CCEL vs MGRX FAQ
Which is bigger, Cryo-Cell International or Mangoceuticals?
Cryo-Cell International (CCEL) is larger, with a market capitalization of $33.46M compared with $2.75M for Mangoceuticals (MGRX).
Are Cryo-Cell International and Mangoceuticals in the same industry?
Yes. Both are classified in the Misc Health and Biotechnology Services industry within the Health Care sector.